Form 4: Argan CEO Exercises, Sells Shares for $1.1M Gain

Argan Inc.'s CEO of Gemma, Charles Edwin Collins IV, exercised stock options and simultaneously sold an equal number of common shares, realizing a significant profit.

Summary

• Charles Edwin Collins IV, Chief Executive Officer of Gemma, a subsidiary of Argan Inc. (AGX), executed a transaction involving the company's common stock.
• On September 24, 2025, Collins exercised 5,000 stock options, which were awarded on September 12, 2018, at an exercise price of $43.10 per share.
• Immediately following the option exercise on September 24, 2025, Collins sold 5,000 shares of Argan Inc. common stock on the open market at a price of $267 per share.
• The transaction was made pursuant to a Rule 10b5-1 pre-arranged trading plan.
• Following these transactions, Collins directly beneficially owns 21,006 shares of common stock and 39,735 derivative securities (options to purchase common stock).

Sentiment

Score: 7

Explanation: The sentiment is positive for the insider due to the significant profit realized from the transaction. For the company, it is largely neutral as it represents a pre-planned compensation-related activity rather than a direct signal of company performance or strategic shift.

Positives

• The reporting person realized a significant gross profit of $1,119,500 from the simultaneous exercise and sale (5,000 shares * ($267 $43.10)).
• The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled and transparent insider trading activity, which can mitigate concerns about opportunistic selling.

Negatives

• The transaction represents a reduction in the reporting person's direct equity exposure to the company's common stock, as the shares acquired through exercise were immediately sold.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction, specifically an option exercise and same-day sale, often executed under a pre-arranged trading plan (Rule 10b5-1). Such transactions are common for executives managing their equity compensation and personal finances, and do not inherently reflect broader industry trends or specific company performance signals beyond the individual's financial planning.

Stakeholder Impact

• Shareholders: May view the CEO's sale as a signal, though the 10b5-1 plan mitigates concerns. The significant profit could be seen positively as a reward for executive performance.
• Employees: No direct impact mentioned.

Key Dates

Keywords

Argan Inc, AGX, Insider Transaction, Stock Option Exercise, Share Sale, CEO Transaction, Form 4, Charles Edwin Collins IV, 10b5-1 Plan